article · The Lancet Microbe
Globally, 1 565 000 people have invasive candidiasis every year. These individuals are mainly immunocompromised people, including critically ill patients in the intensive care unit, people receiving extended use of broad-spectrum antibiotics, and of late, individuals with complications of post-COVID-19 condition (also known as long COVID). Invasive candidiasis is often misdiagnosed and accounts for 995 000 deaths (63·6% of all cases) annually.1 As per estimates, Africa has a greater share of the invasive candidiasis burden than the rest of the world.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.lanmic.2024.100996
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
